184 related articles for article (PubMed ID: 38003826)
1. Viremia and Inflammatory Cytokines in Dengue: Interleukin-2 as a Biomarker of Infection, and Interferon-α and -γ as Markers of Primary versus Secondary Infection.
de Arruda TB; Bavia L; Mosimann ALP; Aoki MN; Sarzi ML; Conchon-Costa I; Wowk PF; Duarte Dos Santos CN; Pavanelli WR; Silveira GF; Bordignon J
Pathogens; 2023 Nov; 12(11):. PubMed ID: 38003826
[TBL] [Abstract][Full Text] [Related]
2. Viral Load and Cytokine Response Profile Does Not Support Antibody-Dependent Enhancement in Dengue-Primed Zika Virus-Infected Patients.
Terzian ACB; Schanoski AS; Mota MTO; da Silva RA; Estofolete CF; Colombo TE; Rahal P; Hanley KA; Vasilakis N; Kalil J; Nogueira ML
Clin Infect Dis; 2017 Oct; 65(8):1260-1265. PubMed ID: 29017246
[TBL] [Abstract][Full Text] [Related]
3. Characterization of type I interferon responses in dengue and severe dengue in children in Paraguay.
Talarico LB; Byrne AB; Amarilla S; Lovera D; Vázquez C; Chamorro G; Acosta PL; Ferretti A; Caballero MT; Arbo A; Polack FP
J Clin Virol; 2017 Dec; 97():10-17. PubMed ID: 29078078
[TBL] [Abstract][Full Text] [Related]
4. Dengue Virus-Infected Dendritic Cells, but Not Monocytes, Activate Natural Killer Cells through a Contact-Dependent Mechanism Involving Adhesion Molecules.
Costa VV; Ye W; Chen Q; Teixeira MM; Preiser P; Ooi EE; Chen J
mBio; 2017 Aug; 8(4):. PubMed ID: 28765218
[TBL] [Abstract][Full Text] [Related]
5. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
[TBL] [Abstract][Full Text] [Related]
6. Differential clinical symptoms among acute phase Indian patients revealed significant association with dengue viral load and serum IFN-gamma level.
Pal T; Dutta SK; Mandal S; Saha B; Tripathi A
J Clin Virol; 2014 Nov; 61(3):365-70. PubMed ID: 25288310
[TBL] [Abstract][Full Text] [Related]
7. Callithrix penicillata: a feasible experimental model for dengue virus infection.
Ferreira MS; de Castro PH; Silva GA; Casseb SM; Dias Júnior AG; Rodrigues SG; Azevedo Rdo S; Costa e Silva MF; Zauli DA; Araújo MS; Béla SR; Teixeira-Carvalho A; Martins-Filho OA; Vasconcelos PF
Immunol Lett; 2014; 158(1-2):126-33. PubMed ID: 24361035
[TBL] [Abstract][Full Text] [Related]
8. Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico.
de la Cruz-Hernández SI; Flores-Aguilar H; González-Mateos S; López-Martinez I; Alpuche-Aranda C; Ludert JE; del Angel RM
Am J Trop Med Hyg; 2013 Mar; 88(3):446-54. PubMed ID: 23339203
[TBL] [Abstract][Full Text] [Related]
9. Cytokine IP-10 and GM-CSF are prognostic biomarkers for severity in secondary dengue infection.
Gowri Sankar S; Alwin Prem Anand A
Hum Immunol; 2021 Jun; 82(6):438-445. PubMed ID: 33766427
[TBL] [Abstract][Full Text] [Related]
10. Clinical, Virological, and Cytokine Profiles of Children Infected with Dengue Virus during the Outbreak in Southern Vietnam in 2017.
Ngwe Tun MM; Nguyen TTT; Ando T; Dumre SP; Soe AM; Buerano CC; Nguyen MT; Le NTN; Pham VQ; Nguyen TH; Le TQM; Morita K; Hasebe F
Am J Trop Med Hyg; 2020 Jun; 102(6):1217-1225. PubMed ID: 32189614
[TBL] [Abstract][Full Text] [Related]
11. Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques.
Mladinich KM; Piaskowski SM; Rudersdorf R; Eernisse CM; Weisgrau KL; Martins MA; Furlott JR; Partidos CD; Brewoo JN; Osorio JE; Wilson NA; Rakasz EG; Watkins DI
Immunogenetics; 2012 Feb; 64(2):111-21. PubMed ID: 21881953
[TBL] [Abstract][Full Text] [Related]
12. Increase of Plasma TNF-
Meena AA; Murugesan A; Sopnajothi S; Yong YK; Ganesh PS; Vimali IJ; Vignesh R; Elanchezhiyan M; Kannan M; Dash AP; Shankar EM
Viral Immunol; 2020; 33(1):54-60. PubMed ID: 31532346
[TBL] [Abstract][Full Text] [Related]
13. Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection.
Chagan-Yasutan H; Ndhlovu LC; Lacuesta TL; Kubo T; Leano PS; Niki T; Oguma S; Morita K; Chew GM; Barbour JD; Telan EF; Hirashima M; Hattori T; Dimaano EM
J Clin Virol; 2013 Dec; 58(4):635-40. PubMed ID: 24239423
[TBL] [Abstract][Full Text] [Related]
14.
Chen YJ; Tsao YC; Ho TC; Puc I; Chen CC; Perng GC; Lien HM
Plants (Basel); 2022 Oct; 11(19):. PubMed ID: 36235496
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue.
Tricou V; Minh NN; Farrar J; Tran HT; Simmons CP
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1309. PubMed ID: 21909448
[TBL] [Abstract][Full Text] [Related]
16. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells.
Chareonsirisuthigul T; Kalayanarooj S; Ubol S
J Gen Virol; 2007 Feb; 88(Pt 2):365-375. PubMed ID: 17251552
[TBL] [Abstract][Full Text] [Related]
17. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
[TBL] [Abstract][Full Text] [Related]
18. Decreased peripheral dendritic cell numbers in dengue virus infection.
De Carvalho Bittencourt M; Martial J; Cabié A; Thomas L; Césaire R
J Clin Immunol; 2012 Feb; 32(1):161-72. PubMed ID: 21969208
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Cytokine Expression Profile in Chikungunya and Dengue Co-Infected and Mono-Infected Patients' Samples.
Krishnan SM; Mahalingam J; Sabarimurugan S; Muthu T; Venkidasamy B; Krishnasamy K; Sharma A; Ramalingam S
Pathogens; 2021 Feb; 10(2):. PubMed ID: 33557110
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide acts synergistically with the dengue virus to induce monocyte production of platelet activating factor and other inflammatory mediators.
Kamaladasa A; Gomes L; Jeewandara C; Shyamali NL; Ogg GS; Malavige GN
Antiviral Res; 2016 Sep; 133():183-90. PubMed ID: 27476044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
